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Abstract
Background—While studies suggest that both dopamine and norepinephrine neurotransmission
support reinforcement learning, the role of dopamine has been emphasized. As a result, little is
known about norepinephrine signaling during reward learning and extinction. Both dopamine and
norepinephrine projections innervate distinct regions of the bed nucleus of the stria terminalis
(BNST), a structure that mediates behavioral and autonomic responses to stress and anxiety. We
investigated whether norepinephrine release in the ventral (v) BNST and dopamine release in the
dorsolateral (dl) BNST correlate with reward learning during intracranial self-stimulation (ICSS).
Methods—Using fast-scan cyclic voltammetry, norepinephrine concentration changes in the
vBNST (n = 12 animals) during ICSS were compared to dopamine changes in the dlBNST (n = 7
animals) and nucleus accumbens (NAc) (n = 5 animals). Electrical stimulation was in the ventral
tegmental area/substantia nigra region.
Results—Whereas dopamine release was evoked by presentation of a cue predicting reward
availability in both dlBNST and NAc, cue-evoked norepinephrine release did not occur in the
vBNST. Release of both catecholamines was evoked by the electrical stimulation. Extracellular
changes in norepinephrine were also studied during extinction of ICSS and compared to results
obtained for dopamine. During extinction of ICSS norepinephrine release in the vBNST occurred
at the time where the stimulation was anticipated whereas dopamine release transiently decreased.
Conclusions—The data demonstrate that norepinephrine release in the vBNST differs from
dopamine release in the dlBNST and the NAc in that it signals the absence of reward rather than
responding to reward predictive cues.
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Introduction
Intracranial self-stimulation (ICSS) is an operant behavior in which animals are conditioned
to press a lever to deliver an electrical stimulation to specific brain regions (1-3). Early
research suggested that norepinephrine was a critical neurotransmitter involved in ICSS
(reviewed in (4)). Anatomical sites that supported ICSS were found near norepinephrine
processes (5), and radioactive norepinephrine and its metabolites were released during
ICSS(6). However, subsequent research found evidence to the contrary (7-10), and
supported a more important role for dopamine in ICSS reward (11). Norepinephrine has also
been suggested to be involved in the extinction of reward based behaviors, although this role
has also been disputed (12-14).
ICSS studies have shown that mesolimbic dopamine neurons projecting from the ventral
tegmental area (VTA) are important in the neural circuitry mediating reward (15). Indeed,
dopamine has been viewed as the primary neurotransmitter involved in the rewarding
aspects of ICSS (3). Our previous studies demonstrated that reward learning can be
investigated by quantifying dopamine changes in the nucleus accumbens (NAc) with
carbon-fiber microelectrodes using fast-scan cyclic voltammetry (16). Transient surges of
extracellular dopamine become time-locked to cues that predict ICSS reward and coincide
with cues associated with cocaine or food reward (17; 18). Since dopamine transients are a
direct result of burst firing of dopaminergic neurons (19), these results concur with
electrophysiological recordings that demonstrated that the firing rate of dopamine neurons
encode for a reward prediction error (20; 21).
In this work we measure the roles of dopamine and norepinephrine during ICSS in the bed
nucleus of the stria terminalis (BNST) and compare them to dopamine responses in the NAc.
The BNST is part of the extended amygdala and serves as a relay center between limbic
brain regions and the hypothalamic paraventricular nucleus (22). The anterior portion of the
BNST receives both dopaminergic and noradrenergic inputs, but they are differentially
distributed (23). The ventral (v) BNST has the highest noradrenergic innervation in the brain
(24) but has little dopamine content (25; 26). In contrast, the dorsolateral (dl) BNST receives
dopaminergic innervation from the VTA and periaqueductal gray but contains negligible
norepinephrine (27-31). The research reported here provides three new insights into the role
of catecholamines in ICSS. First, dopaminergic responses in the dlBNST were found to
resemble dopaminergic responses in the NAc. Second, unlike dopamine, norepinephrine in
the vBNST was not released in response to cues that predicted lever availability. Third,
during extinction, norepinephrine release occurred at the time of the anticipated electrical
stimulation whereas there was a suppression of extracellular dopamine.
Materials and Methods
Animals
Male Sprague-Dawley rats (n = 24, Charles River, NC), aged 90-120 d and weighing
280-380 g, were used. They were individually housed in a controlled temperature
environment with a 12:12 light:dark cycle. Food and water were available ad libitum. All
procedures were approved by the Institutional Animal Care and Use Committee of the
University of North Carolina.
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Rats were anesthetized with ketamine hydrochloride (100 mg/kg) and xylazine
hydrochloride (20 mg/kg) administered intraperitoneally and placed in a stereotaxic frame.
A guide cannula (Bioanalytical Systems, West Lafayette, IL) was positioned above the
dlBNST (anteroposterior (AP) −0.1 mm, mediolateral (ML) +1.6 mm), the vBNST (AP 0.0
mm, ML +1.2 mm), or the NAc (AP 1.7 mm, ML 0.8 mm). Coordinates were from a
stereotaxic atlas (32). An Ag/AgCl reference electrode was implanted contralateral to the
guide cannula in the left forebrain. A bipolar stimulating electrode was implanted in the
VTA/substantia nigra (VTA/SN) (AP −5.2 mm, ML +1.2 mm, dorsoventral (DV) −8.0 to
−9.0 mm). Stimulation at these coordinates also activates the ventral noradrenergic bundle
(VNB) (26). Stainless steel skull screws and dental cement secured all items.
Intracranial Self-Stimulation (ICSS) Training
After each animal recovered to their presurgery weight, ICSS training commenced as
previously described (16). During recording sessions, an audiovisual cue was followed 2 s
later by lever extension. Depression of the lever by the rat delivered an electrical stimulation
to the animal. See Methods and Materials in Supplement 1 for more detail.
On the day of recording, some animals also underwent ICSS extinction where the lever-
press did not deliver the electrical stimulation. When the cue no longer elicited lever-press
behavior, ICSS was reinstated with 1-2 operator-delivered stimulations.
Fast-scan Cyclic Voltammetry
Following successful training, a fresh, glass-sealed carbon-fiber microelectrode (75–100 μm
exposed tip length, 7 m diameter, T-650; Amoco, Greenville, SC (33; 34)) was lowered into
the brain with a micromanipulator inserted into the guide cannula. The microelectrode was
lowered to the dlBNST (DV −6.0 to −7.0 mm), the vBNST (DV −7.2 to −7.7 mm) or the
NAc shell (DV −6.4 to −7.4 mm (16)). The carbon-fiber and Ag/AgCl reference electrodes
were connected to a head-mounted amplifier attached to a commutator (Med-Associates, St.
Albans, VT). Fast-scan cyclic voltammetry was computer-controlled (35). A triangular scan
(−0.4 to +1.3 V, 400 V/s) was repeated every 100 ms. Data were digitized and stored on a
computer using software written in LABVIEW (National Instruments).
Histology
At the end of the experiment, electrode placements were verified by electrolytic lesions
made with the carbon-fiber microelectrodes (Fig. S1 in Supplement 1) (26). Rats were
euthanized with an overdose of urethane (2.0 g/kg) and a lesion was made at the recording
site by applying constant current (20 μA for 10 s). Brains were removed and stored in 10 %
formalin solution for a week before being sectioned into 40 μm coronal slices. The sections
were mounted on slides and viewed with an optical microscope.
Chemicals and Drugs
Chemicals and drugs were reagent-quality and used without further purification. Drugs were
obtained from Sigma-Aldrich (St. Louis, MO, USA). Calibration of the carbon-fiber
microelectrodes with standards for pH, dopamine, and norepinephrine were made in a buffer
(pH 7.4 containing 15 mM Tris, 140 mM NaCl, 3.25 mM KCl, 1.2 mM CaCl2, 1.25 mM
NaH2PO4,1.2 mM MgCl2, and 2.0 mM Na2SO4).
At least one pharmacological agent selective for each catecholamine was administered
intraperitoneally (i.p.) at the end of every experiment (0.6 mL volume) to verify the identity
of the electrochemical signal (26). Cyclic voltammetry cannot be used to distinguish
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dopamine from norepinephrine and thus the pharmacological distinction is required (36).
Desipramine-HCl (DMI, 15 mg/kg), raclopride-HCl (2 mg/kg), and idazoxan-HCl (IDA, 5
mg/kg) were dissolved in saline. GBR 12909 (GBR, 15 mg/kg) was dissolved in water and
diluted in saline. For sites reported in the dlBNST positive responses were obtained to
dopaminergic drugs (GBR, raclopride) but not noradrenergic drugs (DMI, IDA) whereas the
opposite was true in the vBNST (Fig. S2 in Supplement 1) as described in a previous study
(23). The limited chemical selectivity of cyclic voltammetry precludes its use in brain
regions that employ both catecholamines as neurotransmitters.
Data Analysis
Catecholamine concentration changes were quantified using principal component regression
(37; 38). The post-calibration factors were from the average responses obtained with
multiple electrodes in our previous studies (23; 39) (6.9 ± 0.3 pA/(μM·μm2) for dopamine,
and 4.5 ± 0.2 pA/(μM·μm2) for norepinephrine). A residual analysis procedure was used to
verify that the cyclic voltammograms of the trials being predicted were consistent with the
cyclic voltammograms used for calibration (40).
Clampfit 8.1 (Axon Instruments, Foster City, CA, USA) was used to analyze maximal
catecholamine concentration evoked by the cue or lever-press. The half-life (t1/2) for
catecholamine clearance was taken as the time to descend from its maximum to half of that
value (41). Only catecholamine concentrations with signal to noise (S/N) > 3 were
considered as cue- or lever-press evoked catecholamine release. Concentration changes were
evaluated by subtracting the average baseline (−2.0 to 0 s relative to cue or lever-press) from
events after the cue (0.1-2.0 s) or lever-press (2-15 s). Mean values were compared with the
two-tailed Student’s t-test to calculate the level of significance. The coefficient of variation
(CV, the ratio of the standard deviation of the mean) was used to characterize the
catecholamine maximum concentrations. Statistical analysis employed GraphPad Software
version 4.0 (San Diego, CA, USA). Data are represented as mean ± S.E.M. and ‘n’ values
indicate the number of rats.
Results
Cue-evoked Dopamine Concentration Changes in the dlBNST during ICSS
Following ICSS training, catecholamine release was measured in the dlBNST. During
training, the animal learned that a tone and house light were followed 2 s later by lever
extension, and that a lever-press delivered ICSS stimulation to its brain (timing diagram in
Fig. 1A). As shown for a single trial (Fig. 1B), dopamine release occurs both following the
cues and the lever-press. The color plot shows the cyclic voltammograms recorded with the
applied voltage as the ordinate and the abscissa as the acquisition time of the cyclic
voltammogram. The current is encoded in color. The trace above the color plot is the
dopamine concentration extracted from these data by principal component regression. The
low residual confirms that the training set used to extract the dopamine concentrations
describes the data appropriately (Fig. 1C).
Animals were allowed multiple ICSS trials. As shown in this animal, the cue-evoked
maximal dopamine concentration ([DA]cue) was similar with each trial ([DA]cue = 36.7 ±
2.6 nM from the first 30 trials and 30.9 ± 1.8 nM from the last 30 trials, t29 = 1.87, P > 0.05,
Fig. 1D). In contrast, lever-press-evoked dopamine ([DA]stim.) decreased significantly over
trials and fit to a parabolic curve (r2 = 0.81, [DA]stim. = 278 ± 11 nM from the first 30 trials
and 182 ± 3 nM from the last 30 trials, t29 = 9.87, P < 0.0001, Fig. 1D). In both respects, the
responses of dopamine were similar to our findings in the NAc (16). The latency to press
after lever extension was essentially constant indicating that the animal had learned the
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behavior (Fig. 1E). Similar results were obtained in the dlBNST in 6 animals undergoing
identical ICSS training. The average value of [DA]cue was 27.8 ± 5.3 nM and for [DA]stim.
was 216 ± 51 nM.
Pharmacological Effects on Dopamine in the dlBNST
For some animals, dopamine release during ICSS was also monitored following
administration of inhibitors of dopamine uptake (GBR 12909) and norepinephrine uptake
(DMI) (n = 5 animals). When examined 20 minutes after GBR (n = 2), both cue- and lever-
press-evoked dopamine concentrations significantly increased ([DA]cue = 34.8 ± 1.1 nM
before and 63.3 ± 2.0 nM after GBR, t49 = 8.85, P < 0.0001; [DA]stim. = 118 ± 7 nM before
and 427 ± 6 nM after GBR, t49 = 78.05, P < 0.0001, Fig. 2, data recorded when both
responses had stabilized in amplitude). Interestingly, the maximal cue evoked dopamine
shows greater relative variation than do the stimulus-evoked changes. The CV was found to
be 0.281 for cue-evoked dopamine release and 0.109 during electrically-stimulated
dopamine release. The latency to lever-press decreased (but not significantly) after
administration of GBR (predrug = 0.64 ± 0.07 s, after GBR = 0.47 ± 0.05 s, t49 = 1.98, P >
0.05).
In contrast, DMI (n = 3) did not significantly change cue-evoked dopamine concentration in
the dlBNST ([DA]cue = 45.1 ± 2.5 nM before and 41.6 ± 2.0 after DMI, t49 = 0.98, P > 0.05,
representative example in Fig. 3A). There was also no significant change in stimulated
dopamine release ([DA]stim. = 299 ± 4 nM predrug and [DA]stim. = 303 ± 8 nM after DMI,
t49 =0.583, P > 0.05, Fig. 3B). DMI did significantly increase the latency to lever-press
(0.47 ± 0.05 s before and 0.76 ± 0.06 s after DMI, t49 = 3.736, P < 0.001). Following DMI,
this animal was administered GBR. As with GBR alone, cue and lever-press-evoked
dopamine concentrations were increased ([DA]cue = 99.4 ± 4.8 nM, t49 = 10.52, P < 0.0001
and [DA]stim. = 1226 ± 64 nM, t49 = 14.55, P < 0.0001) and the latency to lever-press was
restored to its original value (0.49 ±0.06 s).
Norepinephrine Responses during Maintenance-delay Trials
In a different group of animals, measurements were made in the vBNST to evaluate changes
in extracellular norepinephrine concentration during an identical ICSS task. There was no
response to the cue but norepinephrine increased during the electrical stimulation (Fig. 4A)
that followed the lever-press. The residual (Fig. 4B) was below that predicted for 95 % of
the noise from the training set. In this animal, maximum lever-press-evoked norepinephrine
concentration ([NE]stim.) decreased with subsequent trials ([NE]stim. = 288 ± 8 nM from the
first 30 trials and 213 ± 4 nM from the last 30 trials, t29 = 8.160, P < 0.0001, Fig. 4C),
although the latency to lever-press did not significantly change with trials (Fig. 4D). Similar
results were obtained in 6 other animals. The average value across all trials of [NE]stim was
135 ± 25 nM. The average latency to lever-press from these animals over 100 trials was 1.25
± 0.27 s. Norepinephrine release in response to the cue was never observed, even with
extended training (Fig. S3 in Supplement 1).
Pharmacological Effects on Norepinephrine in the vBNST
In some animals norepinephrine changes during ICSS were evaluated after uptake inhibitors
(n = 3 for GBR and n = 4 for DMI, example in Figure 5). DMI significantly increased
stimulated release following the lever-press (from [NE]stim = 213 ± 3 nM to [NE]stim = 269
± 8 nM after DMI, t49 = 6.57, P < 0.0001, 50 trials) and the evoked signal gradually declined
to predrug levels (Fig. 5A and B). Even following DMI, cue-evoked norepinephrine did not
occur. The latency to lever-press following DMI increased significantly (latency was 0.97 ±
0.16 s before drug and 1.96 ± 0.42 s after drug, t49 = 2.609, P < 0.05, Fig. 5C). In a single
animal that was administered GBR following DMI, the latency to lever-press was restored to
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its original value(0.85 ± 0.02 s). Administration of GBR alone had a slight effect on the
norepinephrine responses to stimulation ([NE]stim = 105 ± 3 nM predrug and [NE]stim = 99
± 2 nM after GBR, t37 = 2.044, P < 0.05, Fig. 6A and B), however it did shorten the latency
to lever-press (1.74 ± 0.26 s before and 0.86 ± 0.19 s after GBR, t37 = 2.801, P < 0.01, Fig
6C).
Extracellular Changes of Dopamine and Norepinephrine during Extinction of ICSS
During extinction, the sequence of cues and lever extension was unchanged; however,
depression of the lever had no consequence. Previous studies have demonstrated that cue-
evoked dopamine release in the NAc decreased across extinction trials and this was
accompanied by a decline in goal-directed behavior (16). In addition we found that
dopamine in the NAc decreased during extinction at the time where the stimulation should
have occurred by18.3 ± 1.4 nM (n = 5, individual example in Figure 7A, lever press
indicated by dashed red line). Identical behavior was observed in the dlBNST in one animal
(Figure 7B). However, due to the low success rate of dlBNST experiments, we primarily
compare the behavior of norepinephrine in the vBNST with that of dopamine in the NAc
shell (implantation success was approximately 17 % in the dlBNST versus 80 % in the
NAc).
During extinction, norepinephrine was still unresponsive to the cue but it increased
following the unrewarded lever-presses (example after the lever-press in one animal is
shown in Fig. 7C). Data that was averaged and analyzed by principal component regression
reveal an increase in norepinephrine concentration (n = 5 rats, 32.3 ± 3.5 nM) following the
lever-press during extinction trials. In two animals, norepinephrine changes during
extinction were examined after administration of DMI. The norepinephrine response to
extinction following the lever-press was significantly enhanced (from 38.0 ± 3.6 to 85.6 ±
13.1 nM following DMI, t5 =4.01, P < 0.01, example in Fig. S4 in Supplement 1), but there
was still no change to the cue. Electrically evoked norepinephrine and ICSS behavior were
restored during subsequent reinstatement trials.
Discussion
Here we found that dopamine release in the dlBNST in response to cues that predict lever
availability closely resembles dopamine changes in the NAc (16; 42). In contrast,
norepinephrine in the vBNST does not respond to the cue, even after prolonged training.
However, both catecholamines are released after the lever-press as a consequence of the
VNB and VTA/SN electrical stimulation. During ICSS extinction, cue-evoked dopamine
disappears in the dlBNST just as in the NAc shell (16). As shown here, extracellular
dopamine actually decreases at the time of the lever-press when electrical stimulation is
expected but not delivered. Remarkably, during extinction, norepinephrine increases at the
expected time of electrical stimulation. The opposite responses of these two catecholamines
in the extended amygdala are in accord with a proposed role of this system in distinct
aspects of the addiction cycle that includes both positive and negative reinforcement
mechanisms (43; 44). Dopamine relays information concerning positive hedonic states
whereas the negative hedonic responses are mediated by norepinephrine (23).
Different Roles for Each Catecholamine in Subregions of the BNST during ICSS
Since the BNST is involved in the regulation of stress, homeostasis, and reward (25; 30;
45-48), activated catecholamine neurotransmission in this region during ICSS was
anticipated. Indeed, previous experiments have demonstrated that dopamine
neurotransmission is promoted in the dlBNST during reward-based behaviors (49; 50),
including ICSS (51). The temporal resolution provided by fast-scan cyclic voltammetry
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allowed us to distinguish catecholamine changes associated with the cues from those
associated with the electrical stimulation. In the dlBNST dopamine was found to increase
both in response to the cues that predict lever availability and during the self-administered
(electrical) stimulation. The cue-evoked responses are similar to those observed in other
dopaminergic regions during reward-based operant behaviors (18; 52-54). The greater
variability of cue-induced dopamine transients when compared to stimulated release has
been reported before (16). While the stimulation activates a uniform population of terminals
on each trial, cue-induced dopamine appears to arise from a more variable activation of
terminals.
This is the first time rapid recordings have been applied to norepinephrine during ICSS, and
it has allowed us to reinvestigate the decades-old question of the role of norepinephrine in
ICSS and extinction. Early studies suggested that the norepinephrine release was associated
with reward function (5; 6). Although our work confirms that norepinephrine release is
evoked by a site that supports ICSS, it is not evoked by the predictive cue. Thus it clearly
plays a different role than dopamine during ICSS.
When an animal acquires cue-reward associations, burst firing of midbrain dopaminergic
neurons occurs at the onset of the cue (20; 21). Previously, we have shown that time-locked
dopamine concentration transients also occur in terminal regions at such times (16; 55).
Thus, dopamine release at the cue is one of the neurochemical responses that immediately
elicits a goal-directed behavior (4; 56). In contrast, cue-evoked norepinephrine was not
observed in the vBNST. This is unlikely to be a consequence of norepinephrine transmission
restricted to a synaptic compartment because considerable evidence indicates that it
communicates extrasynaptically in the BNST (31; 57). Indeed, electrophysiological studies
have shown that noradrenergic neurons in the LC respond to novelty but lack a sustained
response to stimuli (58;59).
To investigate whether selective uptake inhibitors affect ICSS, latency to press following
DMI (NET inhibitor) or GBR 12909 (DAT inhibitor) was examined. In the absence of drug,
the latency to lever-press was quite short because the animals were well trained. Overall,
DMI significantly increased the latency to lever-press (Fig. 5C), consistent with the finding
that acute DMI causes a decrement in ICSS reward (60). Following GBR administration, the
latency to lever-press decreased but not significantly (P > 0.05, n = 5 animals), presumably
because of a ceiling effect. Supporting this assumption, in rats with an average latency to
press of more than1.0 s (example in Fig. 6) or who had previously received DMI, the latency
was significantly decreased after GBR. Consistent with this finding, GBR has been shown to
increase responding for ICSS reward (61).
Opposing Catecholamine Changes during Extinction of ICSS
Since identical dopamine responses were obtained during ICSS in the dlBNST as previously
obtained in the NAc (16), we compared our previous dopamine results to those for
norepinephrine in the vBNST. During ICSS extinction, the decrease in lever-pressing was
accompanied by a significant decrease in cue-evoked phasic dopamine in the NAc shell
across trials (16), similar to that seen during extinction of cocaine self-administration (53).
In addition, extracellular dopamine decreased at the time when the electrical stimulation
should have occurred, consistent with electrophysiological data demonstrating reward
prediction error (62;63).
A role for norepinephrine in the behavior observed during extinction of ICSS has long been
suspected. During extinction of ICSS, animals with lesions of the locus coeruleus pressed
the lever with more vigor and over a prolonged period compared to intact animals (64). This
response was attributed to a failure of locus coeruleus-lesioned rats to pay attention to
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relevant cues. Subsequent research employing lesioned animals have provided support for
this hypothesis (65), consistent with the view from electrophysiological studies in intact
animals that norepinephrine neuronal systems are important in paying attention to the
surrounding environment (66). Further, norepinephrine acting at central β-adrenergic
receptors has been suggested to be important in the retrieval of drug-associated memories
following extinction (67;68). Regardless, our data supports a role for norepinephrine during
extinction. During ICSS, the 2 s cue predicts impending reward availability and results in a
dopamine concentration transient without a change in norepinephrine. However, during
extinction animals now learn that the 2 s cue predicts the absence of reward following a
lever-press. This is associated with a norepinephrine surge. It is unlikely that this surge acts
as a cue-associated signal since it occurs after the 2 s cue and any cues associated with the
press itself (e.g., lever depression, click of the lever etc). A signal at the lever press is critical
so that it can trigger a decline in goal-directed behavior; this requires new learning
concerning the prediction of non-reward, a process that has been linked to norepinephrine
(69; 70).
Alternative hypotheses must also be considered. For example, the vBNST receives
noradrenergic input from the nucleus of the solitary tract as well as the locus coeruleus (71).
These two nuclei have been shown to have quite different responses during aversive events
such as opiate withdrawal (25), and, in the present experiments, we cannot distinguish which
nuclei is the primary contributor to the measured norepinephrine release. In addition to its
role in attention, norepinephrine release has also been associated with aversive stimuli.
Using the same measurement approach, we previously showed that norepinephrine release
was evoked by intraoral quinine infusion, an aversive tastant (23). Because the omission of
reward can be considered aversive, this may also be the origin of the norepinephrine surge
during ICSS extinction. In the prefrontal cortex, extracellular norepinephrine increases
following both aversive and rewarding stimuli (72). However, those changes last for longer
than an hour and it is unclear whether the rapid changes we report here have a similar origin.
Conclusion
Subsecond recordings of catecholamines in subregions of the BNST during ICSS reveal that
time-locked catecholamine changes occur during this reward-seeking behavior. In a manner
quite similar to events in the NAc shell, phasic dopamine release in the dlBNST was evoked
by a cue that had become associated with ICSS. In contrast, there was no evidence of cue-
evoked, phasic norepinephrine in the vBNST during ICSS. Both catecholamines were
released by the stimulation as a consequence of the positioning of the stimulating electrode
in the VTA/SN/VNB. During extinction, the activity of both catecholamines was
dramatically altered. Dopamine release to the cue diminished during ICSS extinction and the
dopamine concentration actually decreased following the lever-press. At this time, when the
cue no longer predicts impending ICSS availability and there is new learning about the
consequence of the lever-press, extracellular norepinephrine increased. These data support
the hypothesis that norepinephrine plays a central role in responses to extinction.
Furthermore, the data demonstrate that catecholamine neurons in subregions of the BNST
encode opposite aspects of learning during goal-directed behavior.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Dopamine changes in the dlBNST during maintenance-delay ICSS. (A) Temporal sequence
of task. (B) Upper; a representative temporal dopamine concentration trace from a single
trial during maintenance-delay ICSS. Principal component regression was used to extract the
time course of the dopamine concentration transients. Dopamine release occurs immediately
following the cue (t = 0, red dotted line) and again after the lever-press (lever out at 2 s,
black dotted line). Red bar shows the stimulus duration. Lower: two-dimensional color plot
representation of the background subtracted cyclic voltammograms collected 2 s before cue
and 6 s after the lever extension. Catecholamine concentration changes are apparent in color
plots at the potential for its oxidation (~ 0.65 V, white dashed line) and its reduction (~ −0.2
V). (C) Residual from principal component analysis. (D) Cue- and lever-press-evoked
dopamine release across trials. (E) Latency to press the lever across trials. Stimulus
parameters: 60 Hz, 40 biphasic pulses, 2 ms pulse width.
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Dopamine increase in the dlBNST during maintenance-delay ICSS after administration of
GBR. (A) Average dopamine concentration traces with a representative ± S.E.M. and two-
dimensional color plots from 50 trials before drug session (predrug, left) and 20 min after
the administration of GBR (15 mg/kg, i.p., right). Principal component regression was used
to extract time course of the dopamine concentration traces. The red bars under the current
traces denote the average onset and duration of electrical stimulation. (B) Cue- and (C)
lever-press-evoked dopamine concentration changes across trials.
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Dopamine concentration changes in the dlBNST and latency to lever-press during
maintenance-delay ICSS before and after administration of DMI. Responses are only shown
for 50 trials after the initial decay in stimulated release had occurred. Maximum dopamine
concentrations following (A) the cue and (B) the lever-press as a function of trial number.
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Norepinephrine changes in the vBNST during maintenance-delay ICSS. (A) Upper; a
representative temporal norepinephrine concentration trace from a single trial during the
task. Principal component regression was used to extract time course of the norepinephrine
concentration transients. Norepinephrine was evoked after the lever-press (lever out at 2 s,
black dotted line) but not after the cue (t = 0, red dotted line). Red bar shows the stimulus
duration. Lower; Two-dimensional color plot representation of the background subtracted
cyclic voltammograms collected 2 s before cue and 6 s after the lever extension.
Catecholamine concentration changes are apparent in color plots at the potential for its
oxidation (~ 0.65 V) and its reduction (~ −0.23 V). (B) Residual from principal component
regression. The dashed line shows the level where 95% of the noise is anticipated. (C)
Norepinephrine concentration changes evoked by self-delivered stimulation in consecutive
trials. (D) Latency to press the lever in consecutive trials.
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Norepinephrine increase in the vBNST during maintenance-delay ICSS after administration
of DMI. (A) Average norepinephrine concentration traces with a representative ± S.E.M.
from ~ 50 trials before drug session (predrug, left) and 20 min after the administration of
DMI (DMI, 15 mg/kg, i.p., right). The red bars under the current traces denote the average
onset and duration of electrical stimulation. Principal component regression was used to
extract the time course of the norepinephrine concentration traces. (B) Lever-press-evoked
norepinephrine concentration change and (C) the latency of lever-press across trials.
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Norepinephrine concentration change in the vBNST and latency of the lever-press during
maintenance-delay ICSS after administration of GBR. (A) Average norepinephrine
concentration traces with a representative ± S.E.M. and from ~ 50 trials 20 min after the
administration GBR (15 mg/kg, i.p.). The red bars under the current traces denote the
average onset and duration of electrical stimulation. Principal component regression was
used to extract time course of the norepinephrine concentration traces. (B) Lever press-
evoked norepinephrine concentration change and (C) the latency of lever-press across trials.
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Catecholamine responses in the NAc (A), dlBNST (B) and vBNST (C) during ICSS
extinction. Each data set is averaged from a single animal. The concentration profiles
(displayed as mean and S.E.M.) above the 2D color plots were extracted using principal
component analysis. Time of lever-press is indicated by the red dotted line. In extinction
trials lever-press was not rewarded with electrical stimulation.
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